Quick Takeaways
- Nantahala Capital Partners Limited Partnership filed SCHEDULE 13G/A for UNICYCIVE THERAPEUTICS, INC. Common Stock, par value $0.001 per share (UNCY).
- Disclosed ownership: 2.8%.
- Date of event: 19 Dec 2024.
Nantahala Capital Partners Limited Partnership - 19 Dec 2024 SCHEDULE 13G/A Report for UNICYCIVE THERAPEUTICS, INC. Common Stock, par value $0.001 per share (UNCY)
- Filing Manager
- Nantahala Capital Partners Limited Partnership
- Reporting Manager
- NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP
- Symbol
- UNCY
- Shares outstanding
- 109,022,500 shares
- Disclosed Ownership
- 3,009,021 shares
- Ownership
- 2.8%
- Form type
- SCHEDULE 13G/A
- Filing time
- 20 Dec 2024, 16:31:08 UTC
- Date of event
- 19 Dec 2024
- Previous filing
- 14 Nov 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Nantahala Capital Partners Limited Partnership disclosed 2.8% ownership in UNICYCIVE THERAPEUTICS, INC. Common Stock, par value $0.001 per share (UNCY) on 19 Dec 2024."
What Changed
- Previous schedule filing date: 14 Nov 2024.
- Current filing was accepted on 20 Dec 2024, 16:31.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 2.8% | 3,009,021 | 0 | 3,009,021 | /s/ Taki Vasilakis | Taki Vasilakis / Chief Compliance Officer Nantahala Capital Management, LLC |